Table 2 Circumstances of diagnosis of cervical cancer at advanced (group B) versus localized (group A) stage
From: Diagnosis of advanced cervical cancer, missed opportunities?
Group A N = 25 | Group B N = 71 | p-value | |
|---|---|---|---|
Routine examination | 15/25 (60%) | 6/65 (9.23%) | < 0.001 |
Cervical cytology screening | 11/24 (45.82%) | 11/68 (16.18%) | 0.003 |
Colposcopy for the diagnosis | 16/25 (64%) | 24/57 (42.11%) | 0.22 |
Vaginal bleeding | 9/25 (36%) | 58/68 (85.29%) | < 0.001 |
Post coital vaginal bleeding | 2/25 (8%) | 9/68 (13.24%) | 0.39 |
Appearance of cervix | 0.04 | ||
Normal appearance | 5/24 (20.83%) | 5/67 (7.46%) | |
Budding | 2/24 (8.33%) | 24/67 (35.82%) | |
Gross erosion, ulcer | 13/24 (54.17%) | 26/67 (38.81%) | |
Local induration | 3/24 (12.50%) | 8/67 (11.94%) | |
Necrosis | 1/24 (4.17%) | 4/67 (5.97%) | |
General symptoms | 0/25 (0%) | 21/67 (31.34%) | 0.001 |